Omeros Corp SEC filings OMER

Omeros Corp has 810 filings in SEC EDGAR's recent list, going back to Mar 31, 2004. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (officer or director change). The company's fiscal year ends on December 31.

Omeros Corp SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Aug 13, 2026 —
424B5 Prospectus supplement Nov 14, 2025 —
S-3ASR Automatic shelf registration Nov 14, 2025 —
424B5 Prospectus supplement Jul 25, 2025 —
S-8 Employee stock plan registration Aug 9, 2023 —
424B5 Prospectus supplement Nov 18, 2022 —
424B3 Prospectus Nov 18, 2022 —
S-3 Shelf registration Nov 9, 2022 —
POS AM Filing Mar 1, 2022 —
S-8 Employee stock plan registration Jun 16, 2021 —
424B5 Prospectus supplement Mar 1, 2021 —
424B5 Prospectus supplement Aug 13, 2020 —
424B5 Prospectus supplement Aug 13, 2020 —
FWP Free writing prospectus Aug 12, 2020 —
424B5 Prospectus supplement Aug 10, 2020 —
424B5 Prospectus supplement Aug 10, 2020 —
FWP Free writing prospectus Aug 10, 2020 —
424B5 Prospectus supplement Dec 6, 2019 —
424B5 Prospectus supplement Dec 4, 2019 —
S-3ASR Automatic shelf registration Dec 4, 2019 —
S-8 Employee stock plan registration Jun 11, 2019 —
POS AM Filing Mar 1, 2019 —
424B5 Prospectus supplement Aug 16, 2017 —
424B5 Prospectus supplement Aug 14, 2017 —
S-3ASR Automatic shelf registration Aug 14, 2017 —
S-8 Employee stock plan registration Jun 21, 2017 —
S-8 Employee stock plan registration Mar 16, 2017 —
424B5 Prospectus supplement Aug 15, 2016 —
424B5 Prospectus supplement Aug 10, 2016 —
424B5 Prospectus supplement Aug 10, 2016 —
424B5 Prospectus supplement Apr 22, 2016 —
424B3 Prospectus Apr 22, 2016 —
S-8 Employee stock plan registration Mar 15, 2016 —
POS AM Filing Mar 15, 2016 —
424B5 Prospectus supplement Mar 15, 2016 —
424B5 Prospectus supplement Jan 6, 2016 —
S-8 Employee stock plan registration Mar 16, 2015 —
424B5 Prospectus supplement Jan 30, 2015 —
424B5 Prospectus supplement Jan 28, 2015 —
S-3ASR Automatic shelf registration Jan 16, 2015 —
S-8 Employee stock plan registration Mar 19, 2014 —
424B5 Prospectus supplement Mar 17, 2014 —
424B5 Prospectus supplement Mar 13, 2014 —
424B5 Prospectus supplement Mar 13, 2014 —
S-3 Shelf registration Oct 17, 2013 —
FWP Free writing prospectus May 10, 2013 —
424B5 Prospectus supplement May 10, 2013 —
S-8 Employee stock plan registration Mar 18, 2013 —
424B5 Prospectus supplement Dec 14, 2012 —
424B5 Prospectus supplement Jun 28, 2012 —
424B5 Prospectus supplement Jun 26, 2012 —
S-8 Employee stock plan registration Mar 19, 2012 —
424B5 Prospectus supplement May 10, 2011 —
S-8 Employee stock plan registration Mar 17, 2011 —
424B3 Prospectus Feb 22, 2011 —
424B3 Prospectus Nov 23, 2010 —
424B3 Prospectus Nov 4, 2010 —
424B3 Prospectus Oct 25, 2010 —
S-3 Shelf registration Oct 8, 2010 —
424B3 Prospectus Aug 30, 2010 —
S-1 Registration statement Aug 10, 2010 —
S-8 Employee stock plan registration Apr 1, 2010 —
S-8 Employee stock plan registration Oct 29, 2009 —
424B4 Prospectus Oct 8, 2009 —
S-1/A Amended registration statement Oct 2, 2009 —
FWP Free writing prospectus Sep 23, 2009 —
S-1/A Amended registration statement Sep 16, 2009 —
S-1/A Amended registration statement Jun 23, 2009 —
S-1/A Amended registration statement May 15, 2009 —
S-1/A Amended registration statement May 8, 2008 —
S-1/A Amended registration statement Apr 1, 2008 —
S-1 Registration statement Jan 9, 2008 —

Showing 72 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
OMER (Nasdaq)
Fiscal year ends
December 31
Incorporated in
WA
Headquarters
Seattle, WA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1285819

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.